Filing Details
- Accession Number:
- 0000899243-21-038191
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-29 16:15:21
- Reporting Period:
- 2021-09-28
- Accepted Time:
- 2021-09-29 16:15:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1754068 | Allovir Inc. | ALVR | Biological Products, (No Disgnostic Substances) (2836) | 831971007 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1818064 | Agustin Melian | C/O Allovir, Inc. 139 Main Street, Suite 500 Cambridge MA 02142 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-09-28 | 3,750 | $24.12 | 472,218 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.23. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.